Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $30.82 is 164.55% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 32.147||$ 36.65|
|Low:||$ 30.70||$ 11.65|
ETFs with MNK as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.97%||SPDR S&P Pharmaceuticals ETF (XPH)||+0.84 (1.97%)|
|2.91%||AdvisorShares Dorsey Wright ADR ETF (AADR)||-7.84 (-14.70%)|
|2.74%||Janus Henderson Small Cap Growth Alpha ETF (JSML)||-0.83 (-2.04%)|
|1.4%||Invesco Russell 2000 Pure Value ETF (PXSV)||-1.69 (-5.23%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. In the past few years, we have executed on Mallinckrodt's ongoing transformation to become an innovation-driven specialty pharmaceuticals growth company through a series of strategic acquisitions and divestitures, developing strong commercial platforms and an increasingly robust pipeline. In doing so, our emphasis has evolved to focus on a development portfolio of treatments for severe and critically ill infants and adults. ... More ...